Primary Open Angle Glaucoma
2 competing products in clinical development for Primary Open Angle Glaucoma.
Pipeline by Phase
Phase 21
Approved1
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Latanoprost plus adjunctive glaucoma medication | Sight Sciences | Approved | Terminated | 77 |
| SBI-100 Ophthalmic Emulsion, 0.5% + SBI-100 Ophthalmic Emulsion, 1.0% + SBI-100 Ophthalmic Emulsion, Placebo | Skye Bioscience | Phase 2 | Completed | 44 |